Diabetes care market
encompasses of technologies, devices and therapeutics in relative to diabetes.
There has been a substantial increase in the amount of diabetes cases
internationally over the last few years. Currently, about millions of people
are in misery because of obesity,
which is a key reason for increase of diabetes in people. Key Players profiled
in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronicand
etc. Novo Nordisk is a leading global provider
of diabetes products. The company also has a headship spot in
hemostasis management, growth hormone therapy and hormone replacement therapy.
The company progresses, manufactures and markets its medical devices and
technologies to hospitals, doctors, researchers, scientists and patients in
approximately 160 countries
- Hormone replacement therapy
- Blood glucose monitoring system